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Abstract
Electron fluxes are constant within cellular metabolism. Donating or accepting electrons, 
either naked or as hydrogen atoms, is one of the most important properties of bioen‐
ergetic networks. These redox reactions fulfill key physiological phenomena such as 
cellular growing, phenotypic differentiation, nutritional adaptations and redox‐depen‐
dent cellular signaling, but when they became unregulated, serious pathologies such as 
degenerative diseases and metabolic disorders arise. The liver being an important meta‐
bolic organ, redox reactions play a strategic role in its main functions: processing of nutri‐
ents, fasting response, xenobiotic managing and circadian activity. However, liver is also 
very sensitive to compounds that disturb redox state such as ethanol, CCl
4
, aflatoxins, 
among others, as well as to stressors such as hypercaloric diets, endocrine disruptors 
and stressful life situations. This chapter reviews concepts related to redox reactions in 
the liver, including metabolic aspects of reactive oxygen species (ROS), prooxidant and 
antioxidant subcellular systems, alterations produced by hepatotoxins, adaptations to 
experimental surgical protocols such as portacaval anastomosis, and participation in can‐
cer. It is out of question that for a better comprehension of the physiopathological events 
in the liver and other metabolic organs, the more complete understanding of the roles 
played by redox reactions will be a necessity.
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1. Introduction
Living organisms are dynamic and complex systems with the notable capacity to continu‐
ously preserve their structural identity, but at the same time, to display functional and 
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
 morphological adaptations in daily terms (circadian rhythms), during ontogeny, as well as 
in the context of evolutionary progression. Since living beings are thermodynamic open sys‐
tems, they are empowered to exchange matter and energy. This competence sustains the intri‐
cate intertwine that make up the metabolic networks present in every cell [1].
For the last 2 billion years (after the transition of oxygenic photosynthesis), in our planet the 
bioenergetic cycle has been defined by two principal and complementary processes: pho‐
tosynthesis and respiration [2]. Indeed, every other chemical and energetic transformation 
that takes place in the cellular milieu is included within this biochemical cycle (Figure 1). 
Inspection of the formula shown in Figure 1 rapidly indicates that carbon‐containing mol‐
ecules oscillate from a reduced (as glucose) to an oxidized state (as carbon dioxide). The 
corollary is that in a general sense, metabolism can be visualized as a collection of reduction‐
oxidation (redox) reactions [3].
Electrons flux is in the pith of the formal definition of redox reactions: it establishes that mol‐
ecules accepting electrons are reduced whereas those that give up electrons are oxidized. 
Therefore, redox reactions always occur between redox pairs. As Albert Szent‐Gyorgyi, the 
prestigious Nobel Prize winner biochemist in 1937, quoted: (1) understanding metabolism is 
to figure out the direction taken by the electrons in transit among molecules and (2) the secret 
of life is to take advantage of the correct flow of the electrons [4]. Electrons in transit can be 
mobilized alone (as in the iron‐sulfur complexes and cytochromes within mitochondrial and 
microsomal electron transport chains) or joined with protons as hydrogen atoms (as in bio‐
chemical transformation among acids, aldehydes and alcohols).
Redox potential (ΔE, quantified in volts) is a physicochemical parameter that measures the 
capacity to either release or accept electrons within a chemical reaction. It characterizes the 
extent of free Gibbs energy (ΔG) and the direction of the electron flow in each redox reaction 
(ΔG = nFΔE, n is the electrons transferred and F is Faraday’s constant). Molecular entities 
with higher (more positive) redox potential have the facility to oxidize molecules with a lower 
(more negative) redox potential [5]. Spontaneous biochemical transformations involve the 
release of metabolic energy as the electrons move from reactions with negative redox poten‐
tial (oxidation of glucose into 2 pyruvates + 4e−, −720 mV) to reactions with positive redox 
potential (reduction of O2 with 2e− into water, +820 mV).
1.1. Liver as a paradigmatic metabolic organ
Certainly, every cell and tissue in the organism shows metabolic activity. However, the liver 
has a special consideration since it is the principal organ in the biochemical processing of 
nutrients and xenobiotics. Distinctive metabolic pathways, such as gluconeogenesis, ureagen‐
esis, assembly of lipoproteins, synthesis of ketone bodies, metabolism of foreign chemical 
substances, lipogenesis, cholesterol formation, glutamine synthesis, and others, take place in 
the different population of hepatocytes: periportal (with high [O2] and oxidative metabolism) and pericentral (with low [O2] and less oxidative metabolism) [6].
Hepatic metabolism comprises synthetic (anabolic) and degradative (catabolic) pathways, 
each one being regulated by particular factors, including: (1) cellular compartments  (oxidative 
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Figure 1. Global energy flux underlying redox cycle between photosynthesis and respiration. Driving by solar 
energy, autotrophic organisms synthetize biomolecules (carbohydrates for example) and oxygen by photosynthesis. 
Heterotrophic organisms oxidize carbohydrates to yield carbon dioxide and water by respiration. The cycle is complete 
when carbon dioxide and water are used again by autotrophic organisms.
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reactions are preponderant in mitochondria and peroxisomes whereas reductive reactions are 
more common in cytosol), (2) available coenzymes (oxidized nicotinamide adenine dinucleo‐
tide (NAD+), reduced nicotinamide adenine dinucleotide (NADH) for catabolism and oxi‐
dized nicotinamide adenine dinucleotide phosphate (NADP+), reduced nicotinamide adenine 
dinucleotide phosphate (NADPH) for anabolism), (3) adenine nucleotides pool (low energy 
charge, AMP‐activated protein kinase (AMPK) activation for catabolism and high energy 
charge, reduced AMPK activity for anabolism) [7].
2. Redox molecules as metabolic regulators
It was thought that reactive oxygen species (ROS) were damaging molecules that were 
associated with the main pathological consequences of oxidative stress. However, recently, 
numerous reports have demonstrated that ROS and reactive nitrogen species (RNS) also play 
important roles in signaling pathways. In this way, the nowadays perspective of prooxidant 
reactions in the cellular milieu is that they form part of the physiological response to internal 
and environmental regulatory factors [8]. Indeed, the liver being one of the major metabolic 
organs, the signaling consequences of ROS and RNS are very relevant in the hepatic tissue.
It is well known that mitochondrial activity is the major source for ROS production, with con‐
sequences in the oxidative phosphorylation coupling affecting the ΔΨ (mitochondrial mem‐
brane potential) as well as several mitochondrial metabolic networks. Eventually, important 
processes such as cell proliferation and apoptosis can be triggered by the mitochondrial pro‐
oxidant condition [9].
During the electron transfer through the mitochondrial respiratory complexes, O2 is eventually reduced to water by receiving two electrons, along the creation of a [H+] gradient that makes 
possible the formation of ATP. However, some electrons “leak” without completing the path‐
way until the cytochrome oxidase complex is achieved. In this case, one electron is received 
by an oxygen molecule forming the anion superoxide (O2−). O2− is produced in the interphase between sites I and II, as well in site III of the electron transfer chain. Within the mitochon‐
dria, O2− is transformed to hydrogen peroxide (H2O2) by mitochondrial superoxide dismutase (SOD2); when it reaches the cytosolic compartment, the O2− is turned into H2O2 by SOD1. In cytosol, the mitochondrial O2− and H2O2 are incorporated to the ROS pool generated mainly by the activity of the family of NADPH oxidases to potentially act as the signaling molecules [8].
H2O2 is itself a metabolic regulator, but at high levels can act as a deleterious factor. H2O2 can be converted into H2O by several antioxidant enzymes: H2O2 can be reduced by peroxiredoxins or glutathione peroxidases, which couple reduction of H2O2 with oxidation of glutathione (GSH). Oxidized peroxiredoxins can be reduced by thioredoxins. Subsequently, oxidized thioredoxins 
become reduced by thioredoxin reductase in a NADPH‐dependent manner. Oxidized gluta‐
thione disulfide (GSSG) is reduced by glutathione reductase again in the presence of NADPH.
H2O2 acts as a signaling factor by oxidizing thiol groups (‐SH HS‐) into disulfide bridges (‐S‐S‐) in cysteine residues of key regulatory proteins (enzymes and receptors). Several years 
ago, some reports postulated that H2O2 showed insulin‐like properties in hepatocytes. This 
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observation was eventually confirmed in the yeast Saccharomyses cerevisiae and supported the 
notion, fully accepted nowadays, that H2O2 could be acting as a signaling molecule in many cellular systems [8]. Figure 2 shows the important role that mitochondria play in the prooxi‐
dant reactions of many cellular functions.
2.1. Cellular proliferation
Another system of ROS modulation well characterized in the liver is the control of growth fac‐
tors by the redox regulation of cysteine residues in tyrosine phosphatases. H2O2 downregulates cyclin D1 and cyclin E to inhibit proliferation and upregulates Bcl‐2‐associated X protein (BAX) to 
induce apoptosis in hepatocytes and MCF‐7 cells (cell line from cancerous mammary gland) [10].
Another example is the modulation of redox‐sensitive cysteine residues in the epidermal 
growth factor (EGF) receptor, which is activated by the action of H2O2.
Other protein factors such as erythropoietin (EPO) and vascular endothelial growth factor 
(VEGF) have been identified as redox regulators of this process.
In response to hypoxic conditions, the hypoxia‐inducible transcription factors (HIFs) are 
upregulated by ROS, especially the ones from mitochondrial source. Paradoxically, in liver 
Figure 2. Mitochondrial handling of reactive oxygen species (ROS). Pro‐oxidant reactions (synthesis of O2− and H2O2) are upregulated by a variety of physiological or pathological events. Mitochondrial activation promotes responses such as 
cell proliferation and activation, as well as cancerous processes.
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and vascular smooth muscle cells, in hypoxic condition there is an increase in mitochondrial 
ROS production from complex III; however, the exact mechanism is not well understood.
In liver and muscle cells, angiotensin II signaling also promotes higher production of mito‐
chondrial ROS, which are necessary to activate downstream responses such as mitogen‐acti‐
vated protein kinases (MAPK) [11].
2.2. Immune system
When an organism is infected primordial T‐cells rapidly proliferate, and differentiate into 
effector T‐cells, and mitochondria contribute to this activation through the production of 
ROS. This has been analyzed adding antioxidants to mice after a viral infection and showing 
that they exhibited a depressed immune system. Data suggest that ROS play an important 
role in T‐cell activation, proliferation and adaptive immune function [12].
2.3. Cancer
A fundamental characteristic of cancerous cells is their uncontrolled proliferation. It has been 
observed that they generate high levels of ROS, especially H2O2; in addition, elevated levels of antioxidants have been detected, maybe to implement a protective cellular response. The final 
equilibrium allows a high rate of ROS synthesis concomitant with a transformed functional 
phenotype.
ROS are responsible of oncogenes activation and/or loss of tumor suppressors enhancing 
mitogenic signaling.
Mutations in mitochondrial DNA result in ROS increase that has been associated to a great 
variety of human cancers. One example is the mutation in the gene of NADH dehydrogenase 
in the mitochondrial complex I, which promotes an elevation of ROS production. The pro‐
oxidant stimulus leads to the proliferation of several human and mouse cell lines, as well as 
tumor formation in rodents. Interestingly, this condition could be rescued by the reconstitu‐
tion of the wild‐type enzymatic activity [13].
3. Anabolism and catabolism. Redox‐sensitive enzymes
Prooxidant reactions play an important role in cellular signaling and redox regulation of met‐
abolic processes such as immune defense, growth, and apoptosis among others. The increase 
in the ROS production requires antioxidant strategies to prevent a potential oxidative damage 
to cellular components. The imbalance of prooxidants and antioxidants leading to cell dam‐
age and tissue injury may cause oxidative stress. Oxidative stress is common in organs and 
tissues with high metabolic and energy turnover, including skeletal and heart muscle, blood 
cells, and liver [14].
It has been recognized as the interplay between energy metabolism and ROS to make pos‐
sible the homeostasis in the liver physiology. As it was mentioned above, redox couples as 
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NADH/NAD+, FADH2/FAD+, and GSH/GSSG are involved in the donation and acceptance of electrons in a variety of reactions. NADPH is a key cofactor for many enzymatic reactions 
in the metabolism, and it is considered as one of the main regulator of the redox potential 
(Figure 3). Its production is required for the regeneration of GSH in mitochondria for scaveng‐
ing mitochondrial ROS through glutathione reductase and peroxidase systems [15]. NADP+ is 
synthesized from NAD+ by NAD+ kinase, whereas NADPH is derived from NADH by three 
major enzymes in the mitochondrial matrix: NAD(P)+ transhydrogenase, NADP+‐dependent 
isocitrate dehydrogenase (IDH) and malic enzyme and by other three cytosolic enzymes in 
cytosol: glucose‐6‐phosphate dehydrogenase (G6PD), 6‐phosphogluconate dehydrogenase in 
the pentose phosphate pathway (PPP), and the malic enzyme.
One of the mechanisms for generating cytosolic NADPH from mitochondrial oxidations 
implies substrates shuttles. This is the case of the shuttle mechanism that involves NADP+‐
dependent IDHs present in both, mitochondrial and extramitochondrial spaces, whereas 
NAD+‐dependent IDH is solely mitochondrial. IDHs catalyze oxidative decarboxylation of iso‐
citrate to α‐ketoglutarate in the tricarboxylic acid cycle (TCA), in a NAD+ or NADP+‐dependent 
manner producing NADH or NADPH, respectively. NADPH may be transported by the iso‐
citrate‐2‐ketoglutarate shuttle by the cytosolic IDH in which liver has a high enzymatic activ‐
ity. NADP+‐dependent IDH is induced by ROS and controls the mitochondrial redox balance. 
A decreased expression of NADP+‐dependent IDH importantly elevates ROS generation, 
lipid peroxidation and DNA fragmentation; consequently, a significant reduced ATP level 
is associated to the mitochondrial damage, whereas overexpression of  NADP+‐dependent 
Figure 3. Redox cycles linking metabolic and antioxidant pathways. Glutathione peroxidase (GPx), glutathione reductase 
(GR), superoxide dismutase (SOD), isocitrate dehydrogenase (IDH), glucose‐6‐phosphate dehydrogenase (G6PD), α‐
ketoglutarate dehydrogenase (α‐KGDH), sirtuin (SIRT), reduced glutathione (GSH), oxidized glutathione (GSSG).
Redox Reactions in the Physiopathology of the Liver
http://dx.doi.org/10.5772/intechopen.68841
161
IDH protects from ROS‐induced damage [16]. Thus, both cytosolic and mitochondrial IDHs 
play important roles in cellular defense against oxidative damage by providing NADPH 
needed for the generation of GSH [17, 18] (Figure 2). Likewise, NADP+‐dependent IDH is 
inactivated by GSSG‐dependent glutathionylation leading to enzyme inactivation, followed 
by GSH‐dependent reactivation, suggesting an alternative modification to the redox regula‐
tion of IDHs [19].
Among enzymes sensitive to redox state is α‐ketoglutarate dehydrogenase (α‐KGDH). α‐
KGDH is a mitochondrial enzyme of the TCA that catalyzes the conversion of α‐ketoglu‐
tarate to succinyl‐CoA, producing NADH that supplies electrons for the respiratory chain 
(Figure 2). α‐KGDH is considered a component of the mitochondrial antioxidant system and 
a key sensor of redox status [20]. It is sensitive to ROS and its inhibition impact significantly 
in the energetic deficit induced by oxidative stress; α‐KGDH can also generate ROS by its 
catalytic action regulated by the NADH/NAD+ ratio [21]. A reversible inhibition of α‐KGDH 
is obtained by glutathionylation. Since α‐KGDH controls supply of reducing equivalents gen‐
erated by the TCA, the redox regulation of α‐KGDH would control energy production in 
response to oxidative stress.
Another source of NADPH required for detoxification of free radicals and peroxides is the 
activity of G6PD, the rate‐limiting enzyme of the PPP (Figure 2). It has an important role for 
cell growth by providing NADPH for redox balance [22] and its expression is induced due to 
oxidative stress [23], whereas the reduction of G6PD sensitizes cells to oxidative stress [24]. 
In humans, mutants of G6PD alleles are associated with hemolytic anemia, while mutants in 
mouse embryonic stem cells by targeted homologous recombination have shown that G6PD 
is essential to protect cells against even mild oxidative stress whereas the null mutant is lethal. 
A high‐carbohydrate, fat‐free diet promotes an increase in hepatic G6PD activity [25], but 
polyunsaturated fatty acids content of the diet decreases its activity. Besides the effect at activ‐
ity level, gene expression is also altered. Inhibition of G6PD gene expression is caused by 
polyunsaturated fatty acids but not by saturated or monounsaturated fatty acids [26]. In the 
liver of young Zucker obese fa/fa rats, G6PD expression and activity are increased prior to the 
onset of diabetes type 2, which seems to be contributing factors for the induction of oxidative 
stress [27].
Furthermore, human G6PD is negatively regulated by acetylation on a phylogenetically con‐
served lysine 403 becoming unable to form active dimers and consequently the loss of activ‐
ity. The exposure to extracellular oxidative stimuli promotes reduced G6PD acetylation due 
to deacetylating activity of sirtuins (SIRTs) (Figure 2). The inhibition of SIRT2 increases cel‐
lular susceptibility to oxidative stress. SIRT2 deletion leads to a higher level of lysine 403 
acetylation and impaired activity of G6PD, whereas the addition of SIRT2 rescues the cell 
death induced by the deletion [28].
In mammals, seven members of SIRT family are known; they have diverse subcellular local‐
ization and activity. SIRT1, SIRT6 and SIRT7 are nuclear, SIRT6 is associated with heterochro‐
matic regions and SIRT7 with nucleoli, SIRT2 is in cytosol, and SIRT3–5 are mitochondrial. 
SIRT1 shows a potent NAD+‐dependent deacetylase activity on lysine 16 of histone H4 that 
could promote the formation of heterochromatin, as well as on lysine 382 of p53, while SIRT6 
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and SIRT7 lack deacetylase activity [29]. Several proteins of this family regulate lifespan in 
diverse organisms and in human cells.
SIRT1 is the homolog of Sir2, a protein with an important role in longevity in yeast, and with 
an important role in mammalian development, metabolic regulation and modulation of cel‐
lular stress response and survival by acting on p53, NF‐κB signaling and FoxO transcription 
factors [29]. SIRT1 is an important metabolic regulator that orchestrates hepatic gluconeogen‐
esis and lipid metabolism, suggesting that it can play an important role in the developing of 
metabolic and age‐related diseases. The effects of SIRT1 are mediated through the induction 
of antioxidant proteins, SOD2, nuclear respiratory factor 1 (NRF1) [30], catalase, peroxire‐
doxins 3 and 5, thioredoxin 2, thioredoxin reductase 2, and uncoupling protein 2 (UCP‐2) via 
formation of forkhead box/peroxisome proliferator‐activated receptor gamma coactivator 1‐α 
complex (FoxO3a/PGC‐1α) [31] (Figure 3).
Increasing ROS level modulates activity of SIRT1. Likewise, SIRT1 activity is regulated by 
AMPK, which is a redox‐sensing enzyme, and a metabolic gauge by increasing cellular NAD+ 
synthesis [32]. AMPK is activated by high AMP/ATP ratio and is sensitive to glutathionyl‐
ation by action of H2O2 and NO that oxide reactive thiol residues [33]. Oxidative stress also induces S‐glutathionylation of SIRT1 and reduces NAD+ level, thus inhibiting SIRT1 activity 
[34]. SIRT1 has an important role in the liver glucose metabolism. Ablation of SIRT1 in liver 
induces lipid accumulation by upregulating lipogenic genes expression and reducing β‐oxi‐
dation, whereas overexpression of SIRT1 protects against hepatic steatosis induced by high‐
fat diet [35]. SIRT1 regulates positively β‐oxidation through the activation of nuclear receptors 
peroxisome proliferator‐activated receptor α (PPARα) that regulates gene expression of lipid 
catabolic genes.
Peroxisomes are oxidative subcellular organelles for H2O2, fatty acids, and cholesterol. PPARs are lipophilic ligand‐activated transcription factors that belong to nuclear hormone receptor 
superfamily with three subtypes: PPARα, PPARγ, and PPARβ/δ [36]. PPARα is mainly pres‐
ent in the liver, playing a relevant role in the fasting response. Additionally, PPARα contrib‐
utes to protection from oxidative stress by upregulating expression of genes of the chaperone 
and proteasome families, with consequences in protein folding and degradation of damaged 
proteins [37]. In cancerous cells, PPARα leads to increased peroxisome proliferation and 
production of ROS contributing to DNA damage [38]. Oxidized lipids are produced during 
oxidative stress and are natural endogenous PPARγ ligands suggesting a role in oxidative 
stress response. PPARγ upregulates the expression of antioxidant and prooxidant genes such 
as catalase, SOD2, GPx3, eNOS and mitochondrial uncoupling protein 2 (UCP‐2), whereas 
downregulates cyclooxygenase‐2 (COX‐2) and iNOS [39].
Handling of cellular oxidative stress involves several metabolic enzymes that are originally 
described as part of other metabolic pathways. Most of these enzymes reduce free‐radical 
production and protect cell from injury. The loss of control in the events that coordinates 
redox homeostasis contributes to oxidative damage, metabolic diseases and progression of 
degenerative diseases associated to aging. Understanding the mechanisms involved in these 
events will contribute to improve the quality of life during physiological or pathological 
conditions.
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4. Redox alterations in hepatotoxicity
The role played by the cellular redox state in the hepatic pathophysiological mechanisms is 
not well defined. Indeed, hepatotoxicity has been much linked to the oxidative status and 
deficiencies in the liver antioxidant system. For instance, in the case of the alcoholic liver 
disease (ALD) mainly represented by a chronic stage of alcoholic steatohepatitis (ASH), alter‐
ations in the cell redox state have been implicated in injured hepatocytes [40]. Ethanol is 
metabolized via alcohol dehydrogenase (ADH), the microsomal ethanol oxidizing system, 
and by catalase in the liver peroxisomes, although the activity of ADH is responsible for most 
of the ethanol catabolism. In this pathway, NAD+ is reduced by a transfer of hydrogen (and 
one electron, e−) to NADH, with the concomitant production of acetaldehyde. The NADP+ can 
be also reduced, and hydrogen equivalents from ethanol, but not NADH, are transferred from 
the cytosol to the mitochondria via a shuttle mechanism such as the malate shuttle, the fatty 
acid elongation cycle, and/or the α‐glycerophosphate cycle; therefore, mitochondria become 
more reduced [41, 42].
Lately, the nonalcoholic steatohepatitis (NASH) is becoming a pathological entity gaining 
a significant public health concern [43]. NASH is a progressive form of nonalcoholic fatty 
liver disease (NAFLD) and features of NASH include steatosis, inflammation and varying 
degrees of fibrosis, and seems to follow a 2‐hit model, where the “1st Hit” involves excess 
of lipid accumulation in the liver, which sensitizes the liver to the “2nd Hit”. This “2nd Hit” 
involves inflammation, oxidative stress, liver damage and fibrosis [44]. Here, multiple cellu‐
lar processes play important roles in maintaining the NAD+/NADH ratio. For example, dur‐
ing glycolysis, β‐oxidation, and the TCA activity, NAD+ is reduced to NADH. Within the 
mitochondria, NADH is oxidized by the electron transport chain enzymes during oxidative 
phosphorylation.
Laboratory animals exposed to high fat diet exhibit impaired oxidative metabolism through 
reduced electron transport chain activity [45]. Then, it is possible that those animals exposed 
to high fat during late gestation and early postnatal life present a state of redox imbalance, 
and although their livers are able to readily reduce NADH during catabolic redox reactions 
(in response to increased fat intake), the ability to replenish NAD+ reserves is reduced due to 
impaired oxidative capacity [46]. High fat feeding is associated with depleted NAD+ reserves 
and reduced SIRTs abundance, both established hallmarks of metabolic aging, and supple‐
mentation with factors reversing the effects of depleted NAD+ reserves, and/or SIRT1 and 
SIRT3 abundance rescue the increased susceptibility to develop severe fatty liver disease in 
the adult life [47].
Liver steatosis induces a reduced state in cytosol and mitochondria of hepatocytes, as dem‐
onstrated by alterations in the NADH/NAD+ ratio calculated from the β‐hydroxybutyrate 
dehydrogenase and lactate dehydrogenase reactions [48]. The increased formation of reduc‐
ing equivalents could impair fatty acids oxidation and the TCA cycle [49], but it could also 
enhance the formation of glycerol‐3‐phosphate and thus lipogenesis [50]. Saturation of lipids 
may also modify cellular redox status. Among free fatty acids, monounsaturated fatty acids, 
such as oleic acids, are less toxic than palmitate, a saturated acid, because the latter increases 
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the NADH/NAD+ ratio and promotes uncoupling between glycolysis and TCA cycle fluxes, 
leading to increased ROS production [51]. The hepatic accumulation of saturated fatty acids 
can promote redox imbalance and the formation of reactive oxygen intermediates, mainly 
inducing endoplasmic reticulum (ER) stress and apoptosis [52].
Moreover, the pathogenesis of early‐stage NASH is characterized by hyperinsulinemia and de 
novo synthesis of fatty acids and nascent triacylglycerides, which are deposited as lipid drop‐
lets within the hepatocytes. Hyperinsulinemia shifts the energy supply from glucose to ketone 
bodies, and the high ketone body concentration induces the overexpression of cytochrome 
P450 2E1 (CYP2E1), resulting in unsaturated fatty acids peroxidation and aldehydes produc‐
tion [53]. The NADPH oxidase‐derived ROS from arachidonic acid peroxidation can induce the 
nuclear translocation of EGR1, which in turn can stimulate the expression of the downstream 
genes ATF3 and GADD45G. ATF3 is a transcription factor involved in cell proliferation, apop‐
tosis, and invasion [54]. The increased redox signaling plays a central role in promoting insulin 
resistance in the liver in early NASH, followed by fibrogenesis through activation of protein 
kinase R (PKR), protein kinase R‐like endoplasmic reticulum kinase (PERK) key stress kinases 
[55]. There is evidence that activation of the purinergic receptor P2X7 can give rise to NADPH 
oxidase activation, leading to Kupffer cell activation, a key event in NASH progression [56].
Peroxisomal oxidation of fatty acids is the normal route of metabolism of very long chain 
fatty acids and dicarboxylic acids, where electrons from FADH2 and NADH are transferred directly to O2 [57]. Moreover, fatty acids not oxidized by mitochondria are mainly oxidized by CYP2E1; a process that further increases ROS production [58]. Therefore, many cellular 
systems are important sources of ROS, including the mitochondrial respiratory chain [59], 
the cytochrome P450s [60], oxidative enzymes (xanthine oxidase, aldehyde oxidase, cyclooxy‐
genase, monoamine oxidase (MAO), and the NADPH oxidase complex) [61]. The uncoupling 
protein 2 (UCP‐2) may also enhance the reoxidation of NADH into NAD+, which is required 
for both β‐oxidation and the TCA [62]; UCP‐2 oxidation might be considered an attempt to 
prevent steatosis by increasing hepatic fatty acid oxidation [63].
Moreover, it is accepted that in the NAFLD, depletion of hepatic antioxidants may contribute 
to the progression of steatosis to NASH by increasing oxidative stress that produces lipid 
peroxidation, inflammation, and fibrosis. Indeed, metabolic adaptations resulting from severe 
GSH deficiency seem to protect against the development of steatohepatitis [64]. In summary, 
all the redox alterations seem to be deeply implicated in the onset of NASH and in its progres‐
sion to liver fibrosis and a putative installation of a cirrhotic process.
However, a possible role of a disturbed cell redox state is much less known in cirrhosis. 
Nonetheless, it has been suggested that collagen metabolism could be influenced by changes in 
redox state. It has been postulated that conversion of glutamic acid to proline [65], a decreased 
NAD+/NADH ratio [66], as well as impediment of proline transport and oxidation, could increase 
the liver proline pool, as a fundamental collagen component in the onset of liver fibrosis [67].
In experimental models of rat liver fibrosis/cirrhosis, mitochondrial function and structure 
show a variety of alterations. ATP synthesis is reduced in rats treated with CCl
4
 or thioacet‐
amide, as well as in rats with secondary biliary cirrhosis. These alterations are compensated 
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by increasing mitochondrial volume per hepatocyte and possible augmentation of extrahe‐
patic ATP production, as an effort for maintaining mitochondrial function in the cirrhotic 
liver [68]. These reports agree with the statement that in perfused cirrhotic livers, a reduced 
cytoplasmic and mitochondrial redox states occur accompanied by a diminished activity in 
the mitochondrial electron‐transport chain [69].
5. Redox alterations in experimental portacaval anastomosis
Portacaval anastomosis (PCA) is a pathological condition that usually accompanies the 
portal hypertension associated to cirrhosis; however, the shunt can occur among a variety 
of portal and systemic veins [70]. Experimentally, PCA is a surgical procedure that com‐
municates a sectioned porta vein to an oval incision in the inferior cava vein. It results in 
a straight flow of the full‐of‐nutrients portal vein from the small intestine directly to the 
systemic circulation. It has been used for a long time to implement experimental models of 
hyperammonemia and the consequent hepatic encephalopathy (HE) [71]. However, only 




+)‐metabolic handling by the liver involves equilibrium between anabolic 
(synthesis of proteins, nucleic acids and amination reactions) and catabolic (urea cycle and 
glutamine synthesis) pathways. Intracellular glutamate plays a key role since high glutamate 
serves as substrate for the synthesis of N‐acetylglutamate, an essential allosteric activator of 
carbamyl phosphate synthetase I, a key regulatory enzyme in the urea cycle in the periportal 
hepatocytes. Nitrogen disposal is complemented by glutamine synthesis (glutamate + NH
4
+) 
in the pericentral hepatocytes [72].
In human adults, approximately 1 mol (about 17 g) of NH
4
+ is produced daily in the liver. Part 
is reutilized in biosynthesis, while the rest is a metabolic disposal with the potential of being 
neurotoxic. Its normal concentration in the portal blood varies from 300 to 600 μM, but in the 
blood leaving the liver the concentration is clearly reduced to 20–60 μM [73]. Other organs 
such as the brain, muscle and kidney play a role in regulating the NH
4
+ levels. Insult to the 
liver, whether acute or chronic in nature, reduces its capacity to metabolize NH
4
+ with the 
consequence to promote in hyperammonemic state, with up to five times elevation of circulat‐
ing NH
4
+ [72]. Although the brain is partially protected by the blood‐brain barrier from toxic 
agents such as ammonia, excessive amounts of NH
4
+ can pass into the brain, constituting the 
principal factor in the onset of HE.
PCA in the rat results in liver atrophy, sustained hyperammonemia, and subtle neurological 
symptoms of HE including abnormal locomotor activity, altered sleep patterns, and modifica‐
tions of neuromuscular coordination. Feeding NH
4
+ salts or resins to the shunted rats leads to 
more severe signs, eventually progressing to coma. Neuropathological examination of these 
rats reveals Alzheimer type II astrocytosis, the histological characteristic of chronic hyperam‐
monemic syndromes [74].
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Oxidative stress is believed to play a role in the pathogenesis of HE because acute doses of 
NH
4
+ are prooxidant [75]. ROS include molecules, such as hydrogen peroxide (H2O2), superox‐ide (O2−) and the hydroxyl radical (OH.). Indeed, there is a physiological role for ROS including cellular proliferation, differentiation and signaling. However, a nonphysiological increase in 
ROS or a decrease in the antioxidant capacity of the organism can lead to an oxidative stress 
condition [76]. NH
4
+ promotes oxidative stress by increasing ROS [77]. In this context, the brain 
is susceptible to oxidative stress due to high content of unsaturated fatty acids prone to peroxi‐
dation, high O2 consumption, elevated Fe2+/Fe3+, and low antioxidant systems [78]. However, a polemic issue has arisen since recent report in a model of hyperammonemia using a four‐week 
PCA rat model did not express any signs of oxidative stress in the frontal cortex and in arterial 
plasma by 4‐hydroxy‐nonenal (4‐HNE)‐linked proteins and detection of carbonyl moieties [70].
Liver is by excellence the main metabolic organ, and shows an extensive handling of prooxi‐
dant reactions; especially during the biochemical transformation of nutrients and the process‐
ing of xenobiotics [79]. However, no information has been reported characterizing putative 
prooxidant reactions during the experimental PCA.
5.1. Lipid peroxidation
Oxygen is needed for proper energetic metabolism and correct mitochondrial function, but 
at the same time, it promotes the formation of ROS and, in consequence, oxidation of biomol‐
ecules. Lipid peroxidation is a suitable assay to estimate prooxidant reactions. By measuring 
the presence of conjugated dienes, it is possible to infer the rate of peroxidative activity under 
“in vivo” conditions, and it is also feasible to deduce the balance between prooxidant reactions 
and antioxidant defenses using the thiobarbituric acid reactive substances (TBARS) assay. 
When the TBARS test is done with Fe2+ supplementation, it offers another set of information: 
Because it enhances the breakdown of hydroperoxides, the Fe2+‐induced lipid peroxidation 
is maximum and gives an idea about the total antioxidant mechanisms and the presence of 
global unsaturated fatty acids present in the studied membrane [80].
Initial observations in hepatic subcellular fractions, liver homogenate and serum from sham 
(n = 10) and PCA (n = 23) operated rats after 8 to 13 weeks of surgery were used to test lipid 
peroxidative activity (data not published). Conjugated dienes and TBARS were quantified 
by standard techniques [81]. Strikingly, rats with PCA showed reduced TBARS levels in the 
liver homogenate and most of the subcellular fractions (Figure 4), whereas conjugated dienes 
showed no changes with lower levels in the mitochondrial fractions (Figure 5). The reduction 
of TBARS was also observed when the assay was supplemented with Fe2+ (Figure 6).
PCA is an experimental protocol to generate a hypofunctional liver condition. The above‐
mentioned information strongly suggests that redox equilibrium within the liver under PCA 
surgery shows a reduction in the prooxidant reactions and/or increase in antioxidant defense. 
More focused experiments are needed to elucidate the underlying mechanism(s), but it is 
interesting to consider the biochemical consequences that the alteration in the portal blood 
flow can promote within the hepatocytes’ redox equilibrium.
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6. Redox alterations in liver cancer
6.1. Redox and carcinogenesis
Hepatocellular carcinoma (HCC) is a relevant problem of public health since it is in the sixth 
place in incidence, and the second in mortality at worldwide level [82]. The main risk factors 
conducing to HCC are viral hepatitis, steatosis and cirrhosis [83]. HCC could be considered 
the final stage of chronic liver disease (CLD), characterized by a persistent presence of inflam‐
mation and oxidative stress [84].
One of the best‐characterized effects of redox changes is related to hepatic carcinogenesis [85]. The 
accumulation of ROS in early stages of hepatic damage produces lipid peroxidation of the cellular 
membranes; the reaction of ROS with the double bounds of polyunsaturated fatty acids results in 
the generation of aldehydes as 4‐hydroxynonenal (4‐HNE), acrolein, crotonaldehyde, and malond‐
ialdehyde, all with the capability of forming DNA adducts and genetic instability [86, 87]. 4‐HNE 
forms exocyclic guanine adducts (4‐HNE‐dG) and consequently induces carcinogenic mutations 
[85]. These mutations affect loci of oncogenes or tumor suppressors conduce to malignant transfor‐
mation. An example is the demonstration that 4‐HNE induce G‐C to A‐T changes in the codon 243 
of the p53 locus, an extensively studied tumor suppressor [88], promoting phenotypic loss [89, 90].
In this context, mechanisms activated by oxidative stress have the capability to influence a 
variety of proteins whose function impact in cancer, by the ability to oxidize thiol residues in 
Figure 4. Effect of portacaval anastomosis on thiobarbituric acid reactive substances (TBARS) assay of liver homogenate, 
subcellular fractions and serum. Sham, false‐operated rats (white bars); shunt, rats with portacaval anastomosis for 
6‐8 weeks (black bars). Data are average ± SEM from at least eight independent observations. *Significant statistical 
difference by t‐student test, p < 0.05.
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a process known as “redox priming” [91]. Examples of these redox sensors are the factor nf‐κB 
[92], oncogenes or tumor suppressors as p53 [93] and Src tyrosine kinase [94].
Interestingly, accumulated evidence suggests that antioxidant systems activated in response 
to oxidative stress, improve the proliferation rate and protect cancer cells from a hostile envi‐
ronment [95, 96]. For example, it was demonstrated that prostaglandin 1 reductase‐1 (Ptgr1), 
an oxidoreductase involved in the catabolism of eicosanoids and LPO‐derived compound as 
4‐HNE, whose expression is regulated by the transcription factor (erythroid‐derived‐2)‐like‐2 
(NRF2) [97], is overexpressed in human HCC biopsies and in samples from experimental 
animals. It was documented that Ptgr‐1 regulates positively the proliferation rate of cells and 
improves their survival in two models of experimental HCC [97], suggesting that this antioxi‐
dant response plays a protumoral role in HCC.
6.2. Redox and hepatocellular carcinoma
A role for redox reactions has been detected during the HCC, from the proliferation of initial 
cancer cells to the dissemination process [96]. At the beginning of CLD, cells have a high 
proliferation rate, since the tumor growth demands nutrient supply and metabolic condition‐
ing; in consequence, important architectural changes occur including the formation of new 
Figure 5. Effect of portacaval anastomosis on conjugated dienes of liver homogenate and subcellular fractions. Sham, 
false‐operated rats (white bars); shunt, rats with portacaval anastomosis for 6‐8 weeks (black bars). Data are average ± 
SEM from at least eight independent observations. *Significant statistical difference by t‐student test, p < 0.05.
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blood vessels and the establishment of specific microenvironment within the tumor. These 
 adaptations make the tumor cells adapt to highly variable O2 concentration environment with successive lapses of hypoxia‐reperfusion [98].
From the metabolic point of view, lack of O2 favors the onset of aerobic glycolysis, by the Warburg’s effect [99]; hypoxia also induces adaptive responses as the expression of special‐
ized proteins named hypoxia‐inducible factors (HIFs) [100]. HIF‐1 is a transcription factor 
formed by two subunits (HIF‐1α and HIF‐1β). Although HIF‐1 is constitutively expressed 
in normoxic conditions, HIF‐α is constantly degraded by prolyl‐hydroxylases; hydroxylated 
residues serve as docking site for von Hippel‐Lindau tumor suppressor protein that is a con‐
stituent of an E3 ubiquitin ligase complex. The ubiquitinated HIF‐1α suffers proteasomal deg‐
radation [101]. Low oxygen tension and some proinflammatory cytokines stabilize HIF‐1α and 
allow its nuclear translocation to regulate key genes for the hypoxic response [100]. HIF‐1α 
mediates the expression of genes that supports tumor growth such as NADH dehydrogenase 
(ubiquinone) 1α subcomplex, 4‐like 2 (NDUFA4L2), a protein that attenuates the activity of 
the mitochondrial complex I, reducing the ROS production in low O2 conditions [102].
It was shown that the kinase inhibitor sorafenib, an antineoplasic extensively used in oncol‐
ogy with potent antiangiogenic effects, induces intratumor oxidative stress that favor drug 
resistance in HCC; the insensibility to the drug requires the action of HIF‐1α regulating the 
Figure 6. Effect of portacaval anastomosis on thiobarbituric acid reactive substances (TBARS) assay supplemented with 
FeSO4 50 (μM) of liver homogenate, subcellular fractions and serum. Sham, false‐operated rats (white bars); shunt, 
rats with portacaval anastomosis for 6‐8 weeks (black bars). Data are average ± SEM from at least eight independent 
observations. *Significant statistical difference by t‐student test, p < 0.05.
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 expression of specific genes. For example, Nf‐κB induces the expression of the antiapoptotic 
protein Bcl‐2 and vascular endothelium growth factor (VEGF) is a potent inductor of angiogen‐
esis [103]. The resultant evasion of apoptosis and genesis of new blood vessels makes evident 
that protective cellular mechanisms are exploited during the progression of cancerous cells.
A role for ROS has also been described in the invasive process particularly in the epithelium to 
mesenchymal transition (EMT). EMT is a differentiation process consisting of the change from 
epithelial to mesenchymal characteristics. Epithelial cells are coupled through specialized 
structures as adherens junctions and exhibit apicobasal polarity, whereas in the mesenchymal 
phenotype the cells lose the coupling with neighbors and acquire migratory abilities [104]. 
EMT is considered the fundamental process in metastasis, being the cytokine TGF‐β an effec‐
tive EMT inductor as well as the growth factors EGF and PDGF [105]. These factors regulate 
the activity of the transcription factor SNAIL [106]. It has been described that in renal tubular 
epithelial cells, TGF‐β induces synthesis of H2O2 and the onset to the EMT [107]. In hepatocar‐cinoma‐derived cells HepG2, the stimulation with the phorbol‐ester TPA, favors the activation 
of protein kinase C (PKC), phosphorylation of ERK and accumulation of ROS, resulting in the 
induction of EMT and cellular migration. These effects were prevented by ROS scavengers, 
suggesting a key role for these molecules in the cell migration promoted by TPA [108].
Recently, it was shown that ROS regulate EMT and cell migration induction through the 
activity of eukaryotic translation initiation factor eIF5A2; the expression pattern in the HCC‐
derived cell line SUN449 correlated with those modified by the knock down of eIF5A2, 
strongly suggesting that eIF5A2 is an effector of ROS signaling [109].
Hepatocellular tumoral cells show a variety of adaptive mechanism in extreme environmental 
conditions (hypoxia, low nutrients) to continue their growth and progression. Thus, under‐
standing carcinoma cells biology requires yet exhaustive research and integrative efforts of 
the available data and an intimate knowledge of redox regulation.
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